Pfizer and BioNTech Submit Data on Vaccine for Kids 5 to 11 The companies said that their vaccine was safe and effective in that age group, and that they would submit a formal request in the coming weeks to U.S. regulators to allow a pediatric dose. https://ift.tt/eA8V8J https://www.nytimes.com

on
The companies said that their vaccine was safe and effective in that age group, and that they would submit a formal request in the coming weeks to U.S. regulators to allow a pediatric dose.

from NYT > Top Stories https://ift.tt/39K2A7B
via IFTTT

Comments

Post a Comment